In the latest episode of KYSCO Oncology Voices, host Dr. Shreyas Kalantri, Hematology and Oncology Chief Fellow at University of Louisville, shares updates on recent advances in non-small cell lung cancer (NSCLC) with renowned experts Dr. Goetz Kloecker and Dr. Firas Badin.
They cover landmark trials such as CheckMate 816 (neoadjuvant immunotherapy) and NeoADAURA (neoadjuvant targeted therapy for EGFR-mutant NSCLC), discussing their implications on practice and the multidisciplinary approach to lung cancer care in Kentucky. With Kentucky having one of the highest lung cancer incidence rates, this episode focuses on how recent trial findings can shape patient outcomes in our state.
Tune in to explore how cutting-edge research is being translated into real-world clinical practices.
Host: Dr. Shreyas Kalantri
Guest: Dr. Goetz Kloecker
Guest: Dr. Firas Badin
The Kentucky Society of Clinical Oncology (KYSCO)
Email: [email protected]